CybeRelease: (OTC: NGXL) Sees 2007 International Revenue $3.6 Million

(CybeRelease, January 17, 2007) - LAKE HARMONY, PA - Nutralogix Laboratories, Inc. (OTC PK: NGXL) projects revenue derived from expanding international sales in 2007 will reach or exceed $3.6 million. The Company expects European revenue to average $125,000 per month and Asian revenue to average $175,000 per month, based on the expansion campaign, focused on advertising, marketing, and development of a much larger distributor base.

The Company has spent many months developing its battle plans for the dramatic expansion campaign. Important strategic alliances in advertising, marketing, and sales have positioned Nutralogix to make this great economic leap forward.

“We at Nutralogix are exhilarated about our prospects for our international development for 2007. Based on current projections, we expect to exceed $3.6 million in international revenue for the year. We will soon be issuing our projections for our domestic revenue, which should be equally exciting,” stated Arne Rotne II, Company CEO/President.

“The Company is prepared to produce a major expanded line of nutraceutical products, dealing with long-term health, virility, and youth maintenance. Additionally, we are preparing to produce substantially greater quantities of our existing products. We also expect to be making a very exciting announcement about a new product to be added to our nutraceutical product lines,” continued Rotne.

To read the complete release, go to http://biz.yahoo.com/bw/070117/20070117005262.html?.v=1.

CybeRelease Gainers are MicroStrategy Incorporated (Nasdaq: MSTR), KLA-Tencor Corporation (Nasdaq: KLAC), DayStar Technologies, Inc. (Nasdaq: DSTI), Joy Global Inc. (Nasdaq: JOYG), Neurocrine Biosciences, Inc. (Nasdaq: NBIX), Endo Pharmaceuticals Holdings Inc. (Nasdaq: ENDP), Jos. A. Bank Clothiers, Inc. (Nasdaq: JOSB) and SAVVIS, Inc. (Nasdaq: SVVS).

CybeRelease Decliners are Electronic Arts Inc. (Nasdaq: ERTS), Blackbaud, Inc. (Nasdaq: BLKB), Wynn Resorts, Limited (Nasdaq: WYNN), Genomic Health, Inc. (Nasdaq: GHDX), Millicom International Cellular S.A. (Nasdaq: MICC), Sears Holdings Corporation (Nasdaq: SHLD), Focus Media Holding Limited (Nasdaq: FMCN) and Ryanair Holdings PLC (Nasdaq: RYAAY).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $995.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact Information

C. P. Barry

Media Contact

CybeRelease.com

Contact via E-mail